Literature DB >> 30924205

Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells.

Manlio Barbarisi1, Alfonso Barbarisi2, Gabriele De Sena2, Emilia Armenia2, Caterina Aurilio2,3, Michele Libutti4, Rosario Vincenzo Iaffaioli5, Gerardo Botti6, Nicola Maurea7, Vincenzo Quagliariello7.   

Abstract

Entities:  

Keywords:  Boswellia Serrata; cancer; glioblastoma; inflammation

Mesh：

Substances：

Year:  2019        PMID： 30924205     DOI： 10.1002/ptr.6354

Source DB:  PubMed          Journal:  Phytother Res        ISSN： 0951-418X            Impact factor:   5.878


× No keyword cloud information.
  9 in total

1.  Galvanotactic Migration of Glioblastoma and Brain Metastases Cells.

Authors:  Falko Lange; Jakob Venus; Daria Shams Esfand Abady; Katrin Porath; Anne Einsle; Tina Sellmann; Valentin Neubert; Gesine Reichart; Michael Linnebacher; Rüdiger Köhling; Timo Kirschstein
Journal:  Life (Basel)       Date:  2022-04-14

2.  Phospholipase D1 inhibition sensitizes glioblastoma to temozolomide and suppresses its tumorigenicity.

Authors:  Dong Woo Kang; Won Chan Hwang; Yu Na Noh; Kang Seo Park; Do Sik Min
Journal:  J Pathol       Date:  2020-09-10       Impact factor: 7.996

Review 3.  Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies.

Authors:  Massimiliano Berretta; Vincenzo Quagliariello; Nicola Maurea; Raffaele Di Francia; Saman Sharifi; Gaetano Facchini; Luca Rinaldi; Michela Piezzo; Ceccarelli Manuela; Giuseppe Nunnari; Monica Montopoli
Journal:  Antioxidants (Basel)       Date:  2020-11-26

4.  Molecular characteristics of single patient-derived glioma stem-like cells from primary and recurrent glioblastoma.

Authors:  Jia Shi; Xuchen Dong; Wei Han; Peng Zhou; Liang Liu; Haiyang Wang; Qianqian Jiang; Haoran Li; Shan Cheng; Suwen Li; Jiaqi Yuan; Zhiyuan Qian; Jun Dong
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

5.  The effectiveness of olibanum orally disintegrating tablet in the treatment of oral aphthous ulcers: A randomized, double-blind, placebo-controlled clinical trial.

Authors:  Rasool Soltani; Zahra Saberi; Syed Mustafa Ghanadian; Azade Taheri; Amir Entezarhojjat
Journal:  J Res Med Sci       Date:  2022-01-29       Impact factor: 1.852

6.  Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature.

Authors:  M Berretta; A Morra; R Taibi; F Monari; N Maurea; M Ippolito; U Tirelli; F Fiorica; L Montella; G Facchini; V Quagliariello; M Montopoli
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

7.  Hesperidin Loaded on Gold Nanoparticles as a Drug Delivery System for a Successful Biocompatible, Anti-Cancer, Anti-Inflammatory and Phagocytosis Inducer Model.

Authors:  Ghassan M Sulaiman; Hanaa M Waheeb; Majid S Jabir; Shaymaa H Khazaal; Yaser Hassan Dewir; Yougasphree Naidoo
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

8.  Acetyl-11-Keto-β-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells.

Authors:  Minghe Lv; Shali Shao; Qi Zhang; Xibing Zhuang; Tiankui Qiao
Journal:  Onco Targets Ther       Date:  2020-01-23       Impact factor: 4.147

9.  Boswellic Acid Synergizes With Low-Level Ionizing Radiation to Modulate Bisphenol Induced-Lung Toxicity in Rats by Inhibiting JNK/ERK/c-Fos Pathway.

Authors:  Somya Z Mansour; Fatma S M Moawed; Monda M M Badawy; Hebatallah E Mohamed
Journal:  Dose Response       Date:  2020-10-30       Impact factor: 2.658
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.